{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:35:01Z","timestamp":1756312501791,"version":"3.40.3"},"publisher-location":"Cham","reference-count":139,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030506209"},{"type":"electronic","value":"9783030506216"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-50621-6_4","type":"book-chapter","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:02:40Z","timestamp":1599480160000},"page":"55-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress"],"prefix":"10.1007","author":[{"given":"Theresa","family":"Ramalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayara","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie L.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Henrique","family":"Serezani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archinte.1930.00140100165015","volume":"45","author":"J Harkavy","year":"1930","unstructured":"Harkavy J (1930) Spam-producing substance in the sputum of patiensts with bronchial asthma. Arch Intern Med 45:641","journal-title":"Arch Intern Med"},{"key":"4_CR2","first-page":"121","volume":"30","author":"C Kellaway","year":"1940","unstructured":"Kellaway C, Trethewie E (1940) The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Q J Exp Physiol Cogn Med Sci 30:121\u2013145","journal-title":"Q J Exp Physiol Cogn Med Sci"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1113\/jphysiol.1938.sp003674","volume":"94","author":"W Feldberg","year":"1938","unstructured":"Feldberg W, Kellaway CH (1938) Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 94:187\u2013226","journal-title":"J Physiol"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1113\/jphysiol.1960.sp006449","volume":"151","author":"W Brocklehurst","year":"1960","unstructured":"Brocklehurst W (1960) The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 151:416\u2013435","journal-title":"J Physiol"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4049\/jimmunol.110.3.760","volume":"110","author":"RP Orange","year":"1973","unstructured":"Orange RP, Murphy RC, Karnovsky ML, Austen KF (1973) The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol 110:760\u2013770","journal-title":"J Immunol"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(78)80332-9","volume":"87","author":"HR Morris","year":"1978","unstructured":"Morris HR, Taylor GW (1978) Slow-reacting substance of anaphylaxis purification and characterisation. FEBS Lett 87:203\u2013206","journal-title":"FEBS Lett"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.76.9.4275","volume":"76","author":"RC Murphy","year":"1979","unstructured":"Murphy RC, Hammarstr\u00f6m S, Samuelsson B (1979) Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci 76:4275\u20134279","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0006-291X(79)91203-8","volume":"91","author":"S Hammarstr\u00f6m","year":"1979","unstructured":"Hammarstr\u00f6m S, Murphy RC, Samuelsson B, Clark DA, Mioskowski C, Corey E (1979) Structure of leukotriene C identification of the amino acid part. Biochem Biophys Res Commun 91:1266\u20131272","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0090-6980(79)90052-2","volume":"17","author":"B Samuelsson","year":"1979","unstructured":"Samuelsson B, Borgeat P, Hammarstr\u00f6m S, Murphy R (1979) Introduction of a nomenclature: leukotrienes. Prostaglandins 17:785\u2013787","journal-title":"Prostaglandins"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1073\/pnas.76.5.2148","volume":"76","author":"P Borgeat","year":"1979","unstructured":"Borgeat P, Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci 76:2148\u20132152","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.76.7.3213","volume":"76","author":"P Borgeat","year":"1979","unstructured":"Borgeat P, Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. Proc Natl Acad Sci 76:3213\u20133217","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI13241","volume":"107","author":"FA Fitzpatrick","year":"2001","unstructured":"Fitzpatrick FA, Soberman R (2001) Regulated formation of eicosanoids. J Clin Invest 107:1347\u20131351","journal-title":"J Clin Invest"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1194\/jlr.R057588","volume":"56","author":"CC Leslie","year":"2015","unstructured":"Leslie CC (2015) Cytosolic phospholipase A2: physiological function and role in disease. J Lipid Res 56:1386\u20131402","journal-title":"J Lipid Res"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","volume":"111","author":"EA Dennis","year":"2011","unstructured":"Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G (2011) Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111:6130\u20136185","journal-title":"Chem Rev"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","volume":"1851","author":"O R\u00e5dmark","year":"2015","unstructured":"R\u00e5dmark O, Werz O, Steinhilber D, Samuelsson B (2015) 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta 1851:331\u2013339","journal-title":"Biochim Biophys Acta"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2007.11.006","volume":"29","author":"JF Evans","year":"2008","unstructured":"Evans JF, Ferguson AD, Mosley RT, Hutchinson JH (2008) What\u2019s all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol Sci 29:72\u201378","journal-title":"Trends Pharmacol Sci"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","volume":"357","author":"M Peters-Golden","year":"2007","unstructured":"Peters-Golden M, Henderson WR Jr (2007) Leukotrienes. N Engl J Med 357:1841\u20131854","journal-title":"N Engl J Med"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","volume":"36","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden M, Gleason MM, Togias A (2006) Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 36:689\u2013703","journal-title":"Clin Exp Allergy"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1568010023344959","volume":"1","author":"O Werz","year":"2002","unstructured":"Werz O (2002) 5-lipoxygenase: cellular biology and molecular pharmacology. Curr Drug Targets Inflamm Allergy 1:23\u201344","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alit.2014.09.001","volume":"64","author":"M Liu","year":"2015","unstructured":"Liu M, Yokomizo T (2015) The role of leukotrienes in allergic diseases. Allergol Int 64:17\u201326","journal-title":"Allergol Int"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.ai.2019.04.002","volume":"142","author":"Y Kanaoka","year":"2019","unstructured":"Kanaoka Y, Austen KF (2019) Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions. Adv Immunol 142:65\u201384","journal-title":"Adv Immunol"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0090-6980(90)90072-4","volume":"39","author":"R Nolfo","year":"1990","unstructured":"Nolfo R, Rankin JA (1990) U937 and THP-1 cells do not release LTB4, LTC4, or LTD4 in response to A23187. Prostaglandins 39:157\u2013165","journal-title":"Prostaglandins"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","volume":"62","author":"A Sala","year":"2010","unstructured":"Sala A, Folco G, Murphy RC (2010) Transcellular biosynthesis of eicosanoids. Pharmacol Rep 62:503\u2013510","journal-title":"Pharmacol Rep"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1073\/pnas.83.5.1349","volume":"83","author":"JE McGee","year":"1986","unstructured":"McGee JE, Fitzpatrick FA (1986) Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci U S A 83:1349\u20131353","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/1523-1747.ep12469865","volume":"100","author":"L Iversen","year":"1993","unstructured":"Iversen L, Fogh K, Ziboh VA, Kristensen P, Schmedes A, Kragballe K (1993) Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase. J Invest Dermatol 100:293\u2013298","journal-title":"J Invest Dermatol"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12329890","volume":"106","author":"J Breton","year":"1996","unstructured":"Breton J, Woolf D, Young P, Chabot-Fletcher M (1996) Human keratinocytes lack the components to produce leukotriene B4. J Invest Dermatol 106:162\u2013167","journal-title":"J Invest Dermatol"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1073\/pnas.92.15.6966","volume":"92","author":"U Janssen-Timmen","year":"1995","unstructured":"Janssen-Timmen U, Vickers PJ, Wittig U, Lehmann WD, Stark HJ, Fusenig NE, Rosenbach T, Radmark O, Samuelsson B, Habenicht AJ (1995) Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc Natl Acad Sci U S A 92:6966\u20136970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1164\/ajrccm\/146.5_Pt_2.S51","volume":"146","author":"SJ Feinmark","year":"1992","unstructured":"Feinmark SJ (1992) The role of the endothelial cell in leukotriene biosynthesis. Am Rev Respir Dis 146:S51\u2013S55","journal-title":"Am Rev Respir Dis"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-015-9721-0_2","volume-title":"Advances in Prostaglandin and Leukotriene research: basic science and new clinical applications","author":"M Peters-Golden","year":"2001","unstructured":"Peters-Golden M, Brock TG (2001) 5-Lipoxygenase and the nucleus: where, when, how, and why? In: Samuelsson B, Paoletti R, Folco GC, Granstr\u00f6m E, Nicosia S (eds) Advances in Prostaglandin and Leukotriene research: basic science and new clinical applications. Springer Netherlands, Dordrecht, pp 9\u201315"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"15359","DOI":"10.1074\/jbc.270.25.15359","volume":"270","author":"S Glover","year":"1995","unstructured":"Glover S, de Carvalho MS, Bayburt T, Jonas M, Chi E, Leslie CC, Gelb MH (1995) Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE\/antigen. J Biol Chem 270:15359\u201315367","journal-title":"J Biol Chem"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/bbrc.1993.2227","volume":"196","author":"M Peters-Golden","year":"1993","unstructured":"Peters-Golden M, McNish RW (1993) Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem Biophys Res Commun 196:147\u2013153","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1172\/JCI117889","volume":"95","author":"JW Woods","year":"1995","unstructured":"Woods JW, Coffey MJ, Brock TG, Singer II, Peters-Golden M (1995) 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest 95:2035\u20132046","journal-title":"J Clin Invest"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1164\/ajrccm.157.6.mar4","volume":"157","author":"M Peters-Golden","year":"1998","unstructured":"Peters-Golden M (1998) Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med 157:S227\u2013S231; discussion S231-222, S247-228","journal-title":"Am J Respir Crit Care Med"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1182\/blood-2003-02-0534","volume":"102","author":"C Canetti","year":"2003","unstructured":"Canetti C, Hu B, Curtis JL, Peters-Golden M (2003) Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102:1877\u20131883","journal-title":"Blood"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smim.2017.08.006","volume":"33","author":"SL Brandt","year":"2017","unstructured":"Brandt SL, Serezani CH (2017) Too much of a good thing: how modulating LTB4 actions restore host defense in homeostasis or disease. Semin Immunol 33:37\u201343","journal-title":"Semin Immunol"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood.V89.6.2122","volume":"89","author":"J Gosselin","year":"1997","unstructured":"Gosselin J, Borgeat P (1997) Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. Blood 89:2122\u20132130","journal-title":"Blood"},{"key":"4_CR37","first-page":"400","volume":"77","author":"M Grone","year":"1992","unstructured":"Grone M, Scheffer J, Konig W (1992) Modulation of leukotriene generation by invasive bacteria. Immunology 77:400\u2013407","journal-title":"Immunology"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1100\/tsw.2007.180","volume":"7","author":"TG Brock","year":"2007","unstructured":"Brock TG, Peters-Golden M (2007) Activation and regulation of cellular eicosanoid biosynthesis. ScientificWorldJournal 7:1273\u20131284","journal-title":"ScientificWorldJournal"},{"issue":"Suppl","key":"4_CR39","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1194\/jlr.R800062-JLR200","volume":"50","author":"O Radmark","year":"2009","unstructured":"Radmark O, Samuelsson B (2009) 5-Lipoxygenase: mechanisms of regulation. J Lipid Res 50(Suppl):S40\u2013S45","journal-title":"J Lipid Res"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2005-0336RC","volume":"34","author":"K Zaman","year":"2006","unstructured":"Zaman K, Hanigan MH, Smith A, Vaughan J, Macdonald T, Jones DR, Hunt JF, Gaston B (2006) Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells. Am J Respir Cell Mol Biol 34:387\u2013393","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","volume":"153","author":"F Bruno","year":"2018","unstructured":"Bruno F, Spaziano G, Liparulo A, Roviezzo F, Nabavi SM, Sureda A, Filosa R, D\u2019Agostino B (2018) Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma. Eur J Med Chem 153:65\u201372","journal-title":"Eur J Med Chem"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(95)12297-4","volume":"348","author":"KA McGill","year":"1996","unstructured":"McGill KA, Busse WW (1996) Zileuton. Lancet 348:519\u2013524","journal-title":"Lancet"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02737605","volume":"17","author":"LM Dub\u00e9","year":"1999","unstructured":"Dub\u00e9 LM, Swanson LJ, Awni W (1999) Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma. Clinical pharmacokinetics and safety. Clin Rev Allergy Immunol 17:213\u2013221","journal-title":"Clin Rev Allergy Immunol"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ml100029k","volume":"1","author":"Y Ducharme","year":"2010","unstructured":"Ducharme Y, Blouin M, Brideau C, Ch\u00e2teauneuf A, Gareau Y, Grimm EL, Juteau H, Lalibert\u00e9 S, MacKay B, Mass\u00e9 F (2010) The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor. ACS Med Chem Lett 1:170\u2013174","journal-title":"ACS Med Chem Lett"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.bi.63.070194.002123","volume":"63","author":"AW Ford-Hutchinson","year":"1994","unstructured":"Ford-Hutchinson AW, Gresser M, Young RN (1994) 5-Lipoxygenase. Annu Rev Biochem 63:383\u2013417","journal-title":"Annu Rev Biochem"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/ajrccm\/147.4.839","volume":"147","author":"BS Friedman","year":"1993","unstructured":"Friedman BS, Bel EH, Buntinx A, Tanaka W, Han YH, Shingo S, Spector R, Sterk P (1993) Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis 147:839\u2013844","journal-title":"Am Rev Respir Dis"},{"key":"4_CR47","first-page":"467","volume":"8","author":"VE Steele","year":"1999","unstructured":"Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomark Prev 8:467\u2013483","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.1144346","volume":"317","author":"AD Ferguson","year":"2007","unstructured":"Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW (2007) Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Science 317:510\u2013512","journal-title":"Science"},{"key":"4_CR49","unstructured":"NCT00353067, C. g. Veliflapon (DG-031) o prevent heart attackes or smoke in patients with a history of heart attack or unstable angina. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00353067"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.1073\/pnas.1710850114","volume":"114","author":"A Stsiapanava","year":"2017","unstructured":"Stsiapanava A, Samuelsson B, Haeggstr\u00f6m JZ (2017) Capturing LTA. Proc Natl Acad Sci U S A 114:9689\u20139694","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smim.2017.08.007","volume":"33","author":"L Bhatt","year":"2017","unstructured":"Bhatt L, Roinestad K, Van T, Springman EB (2017) Recent advances in clinical development of leukotriene B4 pathway drugs. Semin Immunol 33:65\u201373","journal-title":"Semin Immunol"},{"key":"4_CR52","unstructured":"NCT03964558, C. g. I. Mass balance recovery, metabolite, profile and metabolite identification of Acebilustat. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03964558"},{"key":"4_CR53","unstructured":"NCT02443688, C. g. I. EMPIRE CF: A Phase 2 study to evaluate the efficacy, safety and tolerability of CTX-4430 in adult cystic fibrosis patients <p class=\u201cMsoNormal\u201d style=\u201cmargin-bottom:0cm;margin-bottom:.0001pt;text-align: justify; line-height:150%\u201d>. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02443688#wrapper"},{"key":"4_CR54","unstructured":"NCT02385760, C. g. I. CTX-4430 for the treatment of moderate to severe facial Acne vulgaris. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02385760"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","volume":"173","author":"Y Kanaoka","year":"2004","unstructured":"Kanaoka Y, Boyce JA (2004) Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173:1503\u20131510","journal-title":"J Immunol"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2004.03.054","volume":"114","author":"K Parameswaran","year":"2004","unstructured":"Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O\u2019Byrne PM (2004) Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol 114:73\u201379","journal-title":"J Allergy Clin Immunol"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pupt.2005.02.002","volume":"18","author":"I Stelmach","year":"2005","unstructured":"Stelmach I, Bobrowska-Korzeniowska M, Majak P, Stelmach W, Kuna P (2005) The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Pulm Pharmacol Ther 18:374\u2013380","journal-title":"Pulm Pharmacol Ther"},{"key":"4_CR58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121402","volume":"10","author":"E Gounaris","year":"2015","unstructured":"Gounaris E, Heiferman MJ, Heiferman JR, Shrivastav M, Vitello D, Blatner NR, Knab LM, Phillips JD, Cheon EC, Grippo PJ, Khazaie K, Munshi HG, Bentrem DJ (2015) Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation. PLoS One 10:e0121402","journal-title":"PLoS One"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","volume":"288","author":"Y Kanaoka","year":"2013","unstructured":"Kanaoka Y, Maekawa A, Austen KF (2013) Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J Biol Chem 288:10967\u201310972","journal-title":"J Biol Chem"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","volume":"275","author":"CE Heise","year":"2000","unstructured":"Heise CE, O\u2019Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im D-S, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275:30531\u201330536","journal-title":"J Biol Chem"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4168\/aair.2014.6.4.288","volume":"6","author":"Y Kanaoka","year":"2014","unstructured":"Kanaoka Y, Boyce JA (2014) Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res 6:288\u2013295","journal-title":"Allergy Asthma Immunol Res"},{"key":"4_CR62","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.4049\/jimmunol.173.10.6393","volume":"173","author":"K Okunishi","year":"2004","unstructured":"Okunishi K, Dohi M, Nakagome K, Tanaka R, Yamamoto K (2004) A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 173:6393\u20136402","journal-title":"J Immunol"},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2009.05.046","volume":"124","author":"KF Austen","year":"2009","unstructured":"Austen KF, Maekawa A, Kanaoka Y, Boyce JA (2009) The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J Allergy Clin Immunol 124:406\u2013414; quiz 415-406","journal-title":"J Allergy Clin Immunol"},{"key":"4_CR64","volume":"8","author":"HR Foster","year":"2013","unstructured":"Foster HR, Fuerst E, Lee TH, Cousins DJ, Woszczek G (2013) Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes. PLoS One 8:e58305","journal-title":"PLoS One"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1073\/pnas.1605957113","volume":"113","author":"LG Bankova","year":"2016","unstructured":"Bankova LG, Lai J, Yoshimoto E, Boyce JA, Austen KF, Kanaoka Y, Barrett NA (2016) Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99. Proc Natl Acad Sci U S A 113:6242\u20136247","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","volume":"25","author":"P Ciana","year":"2006","unstructured":"Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor. EMBO J 25:4615\u20134627","journal-title":"EMBO J"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","volume":"106","author":"A Maekawa","year":"2009","unstructured":"Maekawa A, Balestrieri B, Austen KF, Kanaoka Y (2009) GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A 106:11685\u201311690","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1046\/j.1365-2222.1999.00710.x","volume":"29","author":"Y Tohda","year":"1999","unstructured":"Tohda Y, Nakahara H, Kubo H, Haraguchi R, Fukuoka M, Nakajima S (1999) Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 29:1532\u20131536","journal-title":"Clin Exp Allergy"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2500\/aap.2012.33.3615","volume":"33","author":"M Gotoh","year":"2012","unstructured":"Gotoh M, Okubo K, Hashiguchi K, Wakabayashi K, Kanzaki S, Tanaka N, Fujioka M, Kawashima K, Suematsu K, Sasaki K, Iwasaki M, Yamamotoya H (2012) Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis. Allergy Asthma Proc 33:459\u2013466","journal-title":"Allergy Asthma Proc"},{"key":"4_CR70","first-page":"22","volume":"108","author":"SW Stoloff","year":"2000","unstructured":"Stoloff SW (2000) The role of LTRAs in the management of persistent asthma. Postgrad Med 108:22\u201331","journal-title":"Postgrad Med"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jb\/mvu078","volume":"157","author":"T Yokomizo","year":"2015","unstructured":"Yokomizo T (2015) Two distinct leukotriene B4 receptors, BLT1 and BLT2. J Biochem 157:65\u201371","journal-title":"J Biochem"},{"key":"4_CR72","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/42506","volume":"387","author":"T Yokomizo","year":"1997","unstructured":"Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387:620\u2013624","journal-title":"Nature"},{"key":"4_CR73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.192.3.421","volume":"192","author":"T Yokomizo","year":"2000","unstructured":"Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192:421\u2013432","journal-title":"J Exp Med"},{"key":"4_CR74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0952-3278(03)00073-5","volume":"69","author":"AM Tager","year":"2003","unstructured":"Tager AM, Luster AD (2003) BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids 69:123\u2013134","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4_CR75","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.4049\/jimmunol.179.8.5454","volume":"179","author":"CM Peres","year":"2007","unstructured":"Peres CM, Aronoff DM, Serezani CH, Flamand N, Faccioli LH, Peters-Golden M (2007) Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. J Immunol 179:5454\u20135461","journal-title":"J Immunol"},{"key":"4_CR76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smim.2017.08.006","volume":"33","author":"SL Brandt","year":"2017","unstructured":"Brandt SL, Serezani CH (2017) Too much of a good thing: how modulating LTB. Semin Immunol 33:37\u201343","journal-title":"Semin Immunol"},{"key":"4_CR77","doi-asserted-by":"crossref","first-page":"41113","DOI":"10.1074\/jbc.M110.175497","volume":"285","author":"F Okamoto","year":"2010","unstructured":"Okamoto F, Saeki K, Sumimoto H, Yamasaki S, Yokomizo T (2010) Leukotriene B4 augments and restores Fc gamma Rs-dependent phagocytosis in macrophages. J Biol Chem 285:41113\u201341121","journal-title":"J Biol Chem"},{"key":"4_CR78","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/IAI.01323-09","volume":"78","author":"P Mancuso","year":"2010","unstructured":"Mancuso P, Lewis C, Serezani CH, Goel D, Peters-Golden M (2010) Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun 78:2264\u20132271","journal-title":"Infect Immun"},{"key":"4_CR79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI43302","volume":"121","author":"CH Serezani","year":"2011","unstructured":"Serezani CH, Lewis C, Jancar S, Peters-Golden M (2011) Leukotriene B4 amplifies NF-\u03baB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. J Clin Invest 121:671\u2013682","journal-title":"J Clin Invest"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.4049\/jimmunol.1302982","volume":"192","author":"Z Wang","year":"2014","unstructured":"Wang Z, Filgueiras LR, Wang S, Serezani AP, Peters-Golden M, Jancar S, Serezani CH (2014) Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation. J Immunol 192:2349\u20132356","journal-title":"J Immunol"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20052349","volume":"203","author":"ND Kim","year":"2006","unstructured":"Kim ND, Chou RC, Seung E, Tager AM, Luster AD (2006) A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med 203:829\u2013835","journal-title":"J Exp Med"},{"key":"4_CR82","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1167\/iovs.05-1238","volume":"47","author":"T Liao","year":"2006","unstructured":"Liao T, Ke Y, Shao W-H, Haribabu B, Kaplan HJ, Sun D, Shao H (2006) Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. Invest Ophthalmol Vis Sci 47:1543\u20131549","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4_CR83","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.105.545616","volume":"112","author":"EA Heller","year":"2005","unstructured":"Heller EA, Liu E, Tager AM, Sinha S, Roberts JD, Koehn SL, Libby P, Aikawa ER, Chen JQ, Huang P, Freeman MW, Moore KJ, Luster AD, Gerszten RE (2005) Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112:578\u2013586","journal-title":"Circulation"},{"key":"4_CR84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.smim.2017.08.005","volume":"33","author":"EW Gelfand","year":"2017","unstructured":"Gelfand EW (2017) Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma. Semin Immunol 33:44\u201351","journal-title":"Semin Immunol"},{"key":"4_CR85","volume":"47","author":"AJ Lee","year":"2015","unstructured":"Lee AJ, Cho KJ, Kim JH (2015) MyD88-BLT2-dependent cascade contributes to LPS-induced interleukin-6 production in mouse macrophage. Exp Mol Med 47:e156","journal-title":"Exp Mol Med"},{"key":"4_CR86","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1194\/jlr.M068882","volume":"58","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Olson RM, Brown CR (2017) Macrophage LTB4 drives efficient phagocytosis of Borrelia burgdorferi via BLT1 or BLT2. J Lipid Res 58:494\u2013503","journal-title":"J Lipid Res"},{"key":"4_CR87","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1096\/fj.12-217000","volume":"27","author":"Y Matsunaga","year":"2013","unstructured":"Matsunaga Y, Fukuyama S, Okuno T, Sasaki F, Matsunobu T, Asai Y, Matsumoto K, Saeki K, Oike M, Sadamura Y, Machida K, Nakanishi Y, Kubo M, Yokomizo T, Inoue H (2013) Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. FASEB J 27:3306\u20133314","journal-title":"FASEB J"},{"key":"4_CR88","first-page":"4678","volume":"24","author":"Y Iizuka","year":"2010","unstructured":"Iizuka Y, Okuno T, Saeki K, Uozaki H, Okada S, Misaka T, Sato T, Toh H, Fukayama M, Takeda N, Kita Y, Shimizu T, Nakamura M, Yokomizo T (2010) Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J 24:4678\u20134690","journal-title":"FASEB J"},{"key":"4_CR89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3858\/emm.2011.43.3.014","volume":"43","author":"J-M Seo","year":"2011","unstructured":"Seo J-M, Cho K-J, Kim E-Y, Choi MH, Chung BC, Kim J-H (2011) Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp Mol Med 43:129","journal-title":"Exp Mol Med"},{"key":"4_CR90","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20132063","volume":"211","author":"M Liu","year":"2014","unstructured":"Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, Yokoyama C, Nakamizo S, Kabashima K, Narumiya S, Shimizu T, Yokomizo T (2014) 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med 211:1063\u20131078","journal-title":"J Exp Med"},{"key":"4_CR91","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/ATVBAHA.109.185793","volume":"29","author":"GY Kim","year":"2009","unstructured":"Kim GY, Lee JW, Cho SH, Seo JM, Kim JH (2009) Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis. Arterioscler Thromb Vasc Biol 29:915\u2013920","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4_CR92","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1476-5381.1996.tb16706.x","volume":"117","author":"H Showell","year":"1996","unstructured":"Showell H, Breslow R, Conklyn M, Hingorani G, Koch K (1996) Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro. Br J Pharmacol 117:1127","journal-title":"Br J Pharmacol"},{"key":"4_CR93","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1164\/ajrccm\/140.6.1712","volume":"140","author":"IM Richards","year":"1989","unstructured":"Richards IM, Griffin RL, Oostveen JA, Morris J, Wishka DG, Dunn CJ (1989) Effect of the selective leukotriene B4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized Guinea pigs. Am Rev Respir Dis 140:1712\u20131716","journal-title":"Am Rev Respir Dis"},{"key":"4_CR94","first-page":"3","volume":"1","author":"C Lawson","year":"1989","unstructured":"Lawson C, Wishka D, Morris J, Fitzpatrick F (1989) Receptor antagonism of leukotriene B4 myotropic activity by the 2, 6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips. J Lipid Mediat 1:3\u201312","journal-title":"J Lipid Mediat"},{"key":"4_CR95","doi-asserted-by":"crossref","first-page":"827096","DOI":"10.1155\/2008\/827096","volume":"2008","author":"TE Adrian","year":"2008","unstructured":"Adrian TE, Hennig R, Friess H, Ding X (2008) The role of PPARgamma receptors and leukotriene B(4) receptors in mediating the effects of LY293111 in pancreatic Cancer. PPAR Res 2008:827096","journal-title":"PPAR Res"},{"key":"4_CR96","first-page":"3232","volume":"8","author":"WG Tong","year":"2002","unstructured":"Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM, Adrian TE (2002) Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8:3232\u20133242","journal-title":"Clin Cancer Res"},{"key":"4_CR97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2004.02.023","volume":"210","author":"R Hennig","year":"2004","unstructured":"Hennig R, Ding XZ, Tong WG, Witt RC, Jovanovic BD, Adrian TE (2004) Effect of LY293111 in combination with gemcitabine in colonic cancer. Cancer Lett 210:41\u201346","journal-title":"Cancer Lett"},{"key":"4_CR98","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2403929","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, McQueen T, Schober W, Rassidakis G, Andreeff M, Konopleva M (2005) Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Leukemia 19:1977\u20131984","journal-title":"Leukemia"},{"key":"4_CR99","unstructured":"ClinicalTrials.gov , L. f. Amebulant, and U. S. N. I. o. Health. 2017. https:\/\/clinicaltrials.gov\/ct2\/results?term=amelubant&Search=Search"},{"key":"4_CR100","unstructured":". Trial Synopsis 543.10: Effect of 14-Day Treatment with BIIL 284 BS on Patients with COPD (Double-Blind, Placebo-Controlled, Randomised, Parallel Group Study).Boehringer Ingelheim. http:\/\/www.trials.boehringer-ingelheim.com\/public\/trial_results_documents\/543\/543.10_U01\u20131368.pdf"},{"key":"4_CR101","unstructured":". Trial Synopsis 543.14: A double-blind, randomized, three parallel group placebocontrolled study to investigate pharmacokinetics, effect on expression of CD11b\/CD18 (Mac-1), as well as safety and efficacy of two oral doses of BIIL 284 BS (dosage: 25 mg daily, 150 mg daily) in patients with rheumatoid arthritis over two weeks. Boehringer Ingelheim. http:\/\/www.trials.boehringer-ingelheim.com\/public\/trial_results_documents\/543\/543.14_U01-1167.pdf ."},{"key":"4_CR102","unstructured":"543.11, T. S. The effect BIIL 284 BS (14 day treatment) on induced-sputum variables in patients with bronchial asthma (a double-blind. randomized, placebo-controlled parallel study). https:\/\/trials.boehringer-ingelheim.com\/trial_results\/clinical_trials_overview\/clinical_trial_result.c=n.i=9.html"},{"key":"4_CR103","unstructured":". Trial Synopsis 543.37: A randomized, double-blind within dose, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of repeated oral doses (15-day dosing) of BIIL 284 BS in adult (150 mg) and pediatric (75 mg) cystic fibrosis patients. Boehringer Ingelheim. http:\/\/www.trials.boehringer-ingelheim.com\/public\/trial_results_documents\/543\/543.37_U03-3277.pdf ."},{"key":"4_CR104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcf.2013.12.009","volume":"13","author":"MW Konstan","year":"2014","unstructured":"Konstan MW, D\u00f6ring G, Heltshe SL, Lands LC, Hilliard KA, Koker P, Bhattacharya S, Staab A, Hamilton A, I. a. C. o. B. T. 543.45 (2014) A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis. J Cyst Fibros 13:148\u2013155","journal-title":"J Cyst Fibros"},{"key":"4_CR105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S (2011) NF-\u03baB, inflammation, and metabolic disease. Cell Metab 13:11\u201322","journal-title":"Cell Metab"},{"key":"4_CR106","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000264498.60702.0d","volume":"100","author":"M B\u00e4ck","year":"2007","unstructured":"B\u00e4ck M, Sultan A, Ovchinnikova O, Hansson GK (2007) 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 100:946\u2013949","journal-title":"Circ Res"},{"key":"4_CR107","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.ijo.0803147","volume":"30","author":"M Kaaman","year":"2006","unstructured":"Kaaman M, Ryd\u00e9n M, Axelsson T, Nordstr\u00f6m E, Sicard A, Bouloumi\u00e9 A, Langin D, Arner P, Dahlman I (2006) ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int J Obes 30:447\u2013452","journal-title":"Int J Obes"},{"key":"4_CR108","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.4049\/jimmunol.1100196","volume":"187","author":"M Spite","year":"2011","unstructured":"Spite M, Hellmann J, Tang Y, Mathis SP, Kosuri M, Bhatnagar A, Jala VR, Haribabu B (2011) Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J Immunol 187:1942\u20131949","journal-title":"J Immunol"},{"key":"4_CR109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2362.2010.02371.x","volume":"41","author":"P Giouleka","year":"2011","unstructured":"Giouleka P, Papatheodorou G, Lyberopoulos P, Karakatsani A, Alchanatis M, Roussos C, Papiris S, Loukides S (2011) Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Investig 41:30\u201338","journal-title":"Eur J Clin Investig"},{"key":"4_CR110","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/db11-1455","volume":"61","author":"I Mothe-Satney","year":"2012","unstructured":"Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, Grimaldi PA, F\u00e9ral CC, Bouloumi\u00e9 A, Van Obberghen E, Neels JG (2012) Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes 61:2311\u20132319","journal-title":"Diabetes"},{"key":"4_CR111","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nm.3800","volume":"21","author":"P Li","year":"2015","unstructured":"Li P, Oh DY, Bandyopadhyay G, Lagakos WS, Talukdar S, Osborn O, Johnson A, Chung H, Mayoral R, Maris M, Ofrecio JM, Taguchi S, Lu M, Olefsky JM (2015) LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat Med 21:239\u2013247","journal-title":"Nat Med"},{"key":"4_CR112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2017.08.022","volume":"190","author":"FR Guimar\u00e3es","year":"2018","unstructured":"Guimar\u00e3es FR, Sales-Campos H, Nardini V, da Costa TA, Fonseca MTC, J\u00fanior VR, Sorgi CA, da Silva JS, Chica JEL, Faccioli LH, de Barros Cardoso CR (2018) The inhibition of 5Lipoxygenase (5-LO) products leukotriene B4 (LTB). Clin Immunol 190:74\u201383","journal-title":"Clin Immunol"},{"key":"4_CR113","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI90350","volume":"127","author":"W Ying","year":"2017","unstructured":"Ying W, Wollam J, Ofrecio JM, Bandyopadhyay G, El Ouarrat D, Lee YS, Oh DY, Li P, Osborn O, Olefsky JM (2017) Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4\/LTB4R1 signaling. J Clin Invest 127:1019\u20131030","journal-title":"J Clin Invest"},{"issue":"3","key":"4_CR114","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/JLB.MA1218-477RR","volume":"106","author":"T Ramalho","year":"2019","unstructured":"Ramalho T, Ramalingam L, Filgueiras L, Festuccia W, Jancar S, Moustaid-Moussa N (2019) Leukotriene-B4 modulates macrophage metabolism and fat loss in type 1 diabetic mice. J Leukoc Biol 106(3):665\u2013675","journal-title":"J Leukoc Biol"},{"key":"4_CR115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1464-5491.2002.00702.x","volume":"19","author":"AM Rosenfalck","year":"2002","unstructured":"Rosenfalck AM, Almdal T, Hilsted J, Madsbad S (2002) Body composition in adults with type 1 diabetes at onset and during the first year of insulin therapy. Diabet Med 19:417\u2013423","journal-title":"Diabet Med"},{"key":"4_CR116","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/s41598-019-39362-4","volume":"9","author":"P Wolf","year":"2019","unstructured":"Wolf P, Fellinger P, Pfleger L, Smajis S, Beiglb\u00f6ck H, Gajdo\u0161\u00edk M, Anderwald CH, Trattnig S, Luger A, Winhofer Y, Kr\u0161\u0161\u00e1k M, Krebs M (2019) Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus. Sci Rep 9:2576","journal-title":"Sci Rep"},{"key":"4_CR117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188474","volume":"12","author":"AR Jones Iv","year":"2017","unstructured":"Jones Iv AR, Coleman EL, Husni NR, Deeney JT, Raval F, Steenkamp D, Dooms H, Nikolajczyk BS, Corkey BE (2017) Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells. PLoS One 12:e0188474","journal-title":"PLoS One"},{"key":"4_CR118","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2337\/db16-0040","volume":"65","author":"I Elias","year":"2016","unstructured":"Elias I, Ferr\u00e9 T, Vil\u00e0 L, Mu\u00f1oz S, Casellas A, Garcia M, Molas M, Agudo J, Roca C, Ruberte J, Bosch F, Franckhauser S (2016) ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-induced obesity and insulin resistance. Diabetes 65:2139\u20132150","journal-title":"Diabetes"},{"key":"4_CR119","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13238-017-0434-2","volume":"9","author":"KA Tamucci","year":"2018","unstructured":"Tamucci KA, Namwanje M, Fan L, Qiang L (2018) The dark side of browning. Protein Cell 9:152\u2013163","journal-title":"Protein Cell"},{"key":"4_CR120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.117.311071","volume":"122","author":"L Honold","year":"2018","unstructured":"Honold L, Nahrendorf M (2018) Resident and monocyte-derived macrophages in cardiovascular disease. Circ Res 122:113\u2013127","journal-title":"Circ Res"},{"key":"4_CR121","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005568","volume":"8","author":"LR Filgueiras","year":"2015","unstructured":"Filgueiras LR, Brandt SL, Wang S, Wang Z, Morris DL, Evans-Molina C, Mirmira RG, Jancar S, Serezani CH (2015) Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes. Sci Signal 8:ra10","journal-title":"Sci Signal"},{"issue":"1","key":"4_CR122","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1038\/s41598-018-32589-7","volume":"8","author":"T Ramalho","year":"2018","unstructured":"Ramalho T, Filgueiras L, Silva-Jr I, Pessoa AFM, Jancar S (2018) Impaired wound healing in type 1 diabetes is dependent on 5-lipoxygenase products. Sci Rep (Nature) 8(1):14164","journal-title":"Sci Rep (Nature)"},{"key":"4_CR123","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","volume":"10","author":"L Zhao","year":"2004","unstructured":"Zhao L, Moos MP, Gr\u00e4bner R, P\u00e9drono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, L\u00f6tzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10:966\u2013973","journal-title":"Nat Med"},{"key":"4_CR124","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.RES.0000028008.99774.7F","volume":"91","author":"M Mehrabian","year":"2002","unstructured":"Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ, Shih W (2002) Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91:120\u2013126","journal-title":"Circ Res"},{"key":"4_CR125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/ATVBAHA.108.181750","volume":"29","author":"H Hlawaty","year":"2009","unstructured":"Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, Feldman L, B\u00e4ck M (2009) Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis. Arterioscler Thromb Vasc Biol 29:518\u2013524","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4_CR126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.43.5.595","volume":"43","author":"S Clarkson","year":"1926","unstructured":"Clarkson S, Newburgh LH (1926) The relation between atherosclerosis and ingested cholesterol in the rabbit. J Exp Med 43:595\u2013612","journal-title":"J Exp Med"},{"key":"4_CR127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/07853890600982737","volume":"38","author":"M B\u00e4ck","year":"2006","unstructured":"B\u00e4ck M, Hansson GK (2006) Leukotriene receptors in atherosclerosis. Ann Med 38:493\u2013502","journal-title":"Ann Med"},{"key":"4_CR128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2015.05.007","volume":"121","author":"DF Ketelhuth","year":"2015","unstructured":"Ketelhuth DF, Hermansson A, Hlawaty H, Letourneur D, Yan ZQ, B\u00e4ck M (2015) The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE\u2212\/\u2212 mice. Prostaglandins Other Lipid Mediat 121:105\u2013109","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4_CR129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvv224","volume":"108","author":"VC de Hoog","year":"2015","unstructured":"de Hoog VC, Bovens SM, de Jager SC, van Middelaar BJ, van Duijvenvoorde A, Doevendans PA, Pasterkamp G, de Kleijn DP, Timmers L (2015) BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury. Cardiovasc Res 108:367\u2013376","journal-title":"Cardiovasc Res"},{"key":"4_CR130","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1096\/fj.08-113274","volume":"22","author":"MP Moos","year":"2008","unstructured":"Moos MP, Mewburn JD, Kan FW, Ishii S, Abe M, Sakimura K, Noguchi K, Shimizu T, Funk CD (2008) Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB J 22:4352\u20134362","journal-title":"FASEB J"},{"key":"4_CR131","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2353\/ajpath.2008.070834","volume":"172","author":"W Jiang","year":"2008","unstructured":"Jiang W, Hall SR, Moos MP, Cao RY, Ishii S, Ogunyankin KO, Melo LG, Funk CD (2008) Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. Am J Pathol 172:592\u2013602","journal-title":"Am J Pathol"},{"key":"4_CR132","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1161\/01.CIR.0000147775.50954.AA","volume":"110","author":"Y Hui","year":"2004","unstructured":"Hui Y, Cheng Y, Smalera I, Jian W, Goldhahn L, Fitzgerald GA, Funk CD (2004) Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110:3360\u20133366","journal-title":"Circulation"},{"key":"4_CR133","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.yjmcc.2010.11.013","volume":"50","author":"UM Becher","year":"2011","unstructured":"Becher UM, Ghanem A, Tiyerili V, F\u00fcrst DO, Nickenig G, Mueller CF (2011) Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. J Mol Cell Cardiol 50:570\u2013577","journal-title":"J Mol Cell Cardiol"},{"key":"4_CR134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041786","volume":"7","author":"E Nobili","year":"2012","unstructured":"Nobili E, Salvado MD, Folkersen L, Castiglioni L, Kastrup J, Wetterholm A, Tremoli E, Hansson GK, Sironi L, Haeggstr\u00f6m JZ, Gabrielsen A (2012) Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS One 7:e41786","journal-title":"PLoS One"},{"key":"4_CR135","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1378\/chest.07-0831","volume":"132","author":"H Allayee","year":"2007","unstructured":"Allayee H, Hartiala J, Lee W, Mehrabian M, Irvin CG, Conti DV, Lima JJ (2007) The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest 132:868\u2013874","journal-title":"Chest"},{"key":"4_CR136","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","volume":"129","author":"E Ingelsson","year":"2012","unstructured":"Ingelsson E, Yin L, B\u00e4ck M (2012) Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol 129:702\u2013707.e702","journal-title":"J Allergy Clin Immunol"},{"key":"4_CR137","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-017-2242-2","volume":"73","author":"M Hoxha","year":"2017","unstructured":"Hoxha M, Rovati GE, Cavanillas AB (2017) The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol 73:799\u2013809","journal-title":"Eur J Clin Pharmacol"},{"key":"4_CR138","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1165\/ajrcmb\/8.6.668","volume":"8","author":"C Emala","year":"1993","unstructured":"Emala C, Black C, Curry C, Levine MA, Hirshman CA (1993) Impaired beta-adrenergic receptor activation of adenylyl cyclase in airway smooth muscle in the basenji-greyhound dog model of airway hyperresponsiveness. Am J Respir Cell Mol Biol 8:668\u2013675","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4_CR139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2017.06.003","volume":"136","author":"Y Amrani","year":"2017","unstructured":"Amrani Y, Bradding P (2017) \u03b22-Adrenoceptor function in asthma. Adv Immunol 136:1\u201328","journal-title":"Adv Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Druggable Lipid Signaling Pathways"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-50621-6_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T23:09:23Z","timestamp":1696633763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-50621-6_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030506209","9783030506216"],"references-count":139,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-50621-6_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"8 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}